Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erlinda M Gordon

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Frontiers in Molecular Medicine|October 3, 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndromeGrace Haroun, Erlinda M Gordon
International Journal of Oncology|July 7, 2009
The 'timely' development of Rexin-G: first targeted injectable gene vector (review)Erlinda M Gordon, Frederick L Hall
Frontiers in Molecular Medicine|August 1, 2024
The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospectiveErlinda M Gordon, Frederick L Hall
Expert Opinion on Biological Therapy|April 14, 2010
Rexin-G, a targeted genetic medicine for cancerErlinda M Gordon, Frederick L Hall
Oncology Reports|May 5, 2005
Nanotechnology blooms, at last (Review)Erlinda M Gordon, Frederick L Hall
International Journal of Oncology|April 30, 2010
Noteworthy clinical case studies in cancer gene therapy: tumor-targeted Rexin-G advances as an efficacious anti-cancer agentErlinda M Gordon, Frederick L Hall
Frontiers in Molecular Medicine|August 1, 2024
Editorial: Celebrating the 200th mendel's anniversary: gene-targeted diagnostics and therapies for cancerNoah Federman, Erlinda M Gordon, Sant P Chawla, et al.
Advances in Therapy|May 29, 2016
Trabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesErlinda M Gordon, K Kumar Sankhala, Neal Chawla, et al.
Molecular Imaging|August 19, 2003
Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivoMian M Alauddin, Atranik Shahinian, Erlinda M Gordon, et al.
Molecular Imaging|August 7, 2004
Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer modelMian M Alauddin, Atranik Shahinian, Erlinda M Gordon, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Frontiers in Molecular Medicine|October 3, 2024
DeltaRex-G, tumor targeted retrovector encoding a CCNG1 inhibitor, for CAR-T cell therapy induced cytokine release syndromeGrace Haroun, Erlinda M Gordon
International Journal of Oncology|July 7, 2009
The 'timely' development of Rexin-G: first targeted injectable gene vector (review)Erlinda M Gordon, Frederick L Hall
Frontiers in Molecular Medicine|August 1, 2024
The advent of a pan-collagenous CLOVIS POINT for pathotropic targeting and cancer gene therapy, a retrospectiveErlinda M Gordon, Frederick L Hall
Expert Opinion on Biological Therapy|April 14, 2010
Rexin-G, a targeted genetic medicine for cancerErlinda M Gordon, Frederick L Hall
Oncology Reports|May 5, 2005
Nanotechnology blooms, at last (Review)Erlinda M Gordon, Frederick L Hall
International Journal of Oncology|April 30, 2010
Noteworthy clinical case studies in cancer gene therapy: tumor-targeted Rexin-G advances as an efficacious anti-cancer agentErlinda M Gordon, Frederick L Hall
Frontiers in Molecular Medicine|August 1, 2024
Editorial: Celebrating the 200th mendel's anniversary: gene-targeted diagnostics and therapies for cancerNoah Federman, Erlinda M Gordon, Sant P Chawla, et al.
Advances in Therapy|May 29, 2016
Trabectedin for Soft Tissue Sarcoma: Current Status and Future PerspectivesErlinda M Gordon, K Kumar Sankhala, Neal Chawla, et al.
Molecular Imaging|August 19, 2003
Evaluation of 2'-deoxy-2'-flouro-5-methyl-1-beta-D-arabinofuranosyluracil as a potential gene imaging agent for HSV-tk expression in vivoMian M Alauddin, Atranik Shahinian, Erlinda M Gordon, et al.
Molecular Imaging|August 7, 2004
Direct comparison of radiolabeled probes FMAU, FHBG, and FHPG as PET imaging agents for HSV1-tk expression in a human breast cancer modelMian M Alauddin, Atranik Shahinian, Erlinda M Gordon, et al.
Pageof 4